Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm-Reference-Cited by-同舟云学术

Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm

Published:2013-03-07 Issue:5 Volume:62 Page:764-770
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Hwang Keumrock¹,Park Chan-Jeoung¹,Jang Seongsoo¹,Chi Hyun-Sook¹,Huh Joo-Ryung²,Lee Je Hwan³,Suh Cheolwon³,Lee Kyoo Hyung³

Affiliation:

1. Department of Laboratory Medicine; University of Ulsan College of Medicine and Asan Medical Centre; Seoul; Korea

2. Department of Pathology; University of Ulsan College of Medicine and Asan Medical Centre; Seoul; Korea

3. Department of Internal Medicine; University of Ulsan College of Medicine and Asan Medical Centre; Seoul; Korea

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/his.12079/fullpdf

Reference17 articles.

1. Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?;Dalle;Br. J. Dermatol.,2010

2. CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature;Bekkenk;Ann. Oncol.,2004

3. Primary cutaneous blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation: case report and review of the literature;Li;Pathol. Res. Pract.,2011

4. Agranular CD4+ CD56+ hematodermic neoplasm (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes;Petrella;Am. J. Surg. Pathol.,2002

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies;Journal of Biomedical Science;2024-01-12

2. IL-3 in the development and function of basophils;Seminars in Immunology;2021-04

3. CD123 as a Therapeutic Target Against Malignant Stem Cells;Hematology/Oncology Clinics of North America;2020-06

4. Dendritic Cell Leukemia: a Review;Current Oncology Reports;2020-05-15

5. Chimeric antigen receptor therapy in hematological malignancies: antigenic targets and their clinical research progress;Annals of Hematology;2020-05-09